| Abstract | Three patients with polymyositis refractory to conventional steroid and immunosuppressive treatment, but responsive to cyclosporin A, are described. In a fourth patient cyclosporin A was used as a first line drug in combination with steroids in the treatment of life-threatening dermatomyositis. Cyclosporin A in the management of polymyositis/dermatomyositis requires formal assessment of its costs and benefits compared with conventional treatments. |
| Authors | C J Lueck, P Trend, M Swash
(Affiliation: Department of Neurology, Royal London Hospital, UK.)
|
| Journal | Journal of neurology, neurosurgery, and psychiatry
(J Neurol Neurosurg Psychiatry)
Vol. 54
Issue 11
Pg. 1007-8
(Nov 1991)
ISSN: 0022-3050 ENGLAND |
| PMID | 1800644
(Publication Type: Case Reports, Journal Article)
|
| Chemical References |
|
| Topics |
- Adult
- Cyclosporine
(therapeutic use)
- Dermatomyositis
(drug therapy)
- Female
- Humans
- Middle Aged
- Myositis
(drug therapy)
|
